Startseite Antihyperlipidemic Agents Cause a Decrease in von Willebrand Factor Levels in Pediatric Patients with Familial Hyperlipidemia
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Antihyperlipidemic Agents Cause a Decrease in von Willebrand Factor Levels in Pediatric Patients with Familial Hyperlipidemia

  • S. Songül Yalçin , Bülent Güneş , Şule Ünal , Fatma Gümrük und Turgay Coşkun
Veröffentlicht/Copyright: 17. September 2010
Journal of Pediatric Endocrinology and Metabolism
Aus der Zeitschrift Band 23 Heft 8

ABSTRACT

Familial hyperlipidemia is a group of genetic disorders with a predisposition to atherosclerosis. Hyperlipidemia causes increased atherosclerotic events through increased endothelial damage. In this report we aimed to measure the plasma fibrinogen and von Willebrand factor antigen (VWf:Ag) levels in pediatric patients with familial hyperlipidemias and to investigate the effects of serum lipid levels and antihyperlipidemic agents on these parameters. Of the 41 patients analyzed, vWf:Ag level was significantly lower in antihyperlipidemic receivers (132±51%, 102±19%; p=0.010). This finding may indicate that early initiation of antihyperlipidemics in patients with familial hyperlipidemias may decrease the risk of future atherosclerotic events through not only decreasing the serum lipid levels, but also decreasing plasma vWf:Ag levels.


Corresponding author: Prof. Dr. Turgay Coşkun,
Corresponding author:

Published Online: 2010-09-17
Published in Print: 2010-August

© Freund Publishing House Ltd. 2010

Heruntergeladen am 20.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem.2010.126/pdf
Button zum nach oben scrollen